期刊文献+

全骨髓贴壁法分离培养大鼠骨髓间充质干细胞的生物学特性及优势 被引量:6

Biological characteristics and superiority of rat bone marrow mesenchymal stem cells isolated and cultured using whole bone marrow adherence method
下载PDF
导出
摘要 背景:骨髓来源的间充质干细胞含量极低,体外纯化、扩增活性好、分化潜能高的骨髓间充质干细胞,对进一步研究至关重要。目的:进一步验证全骨髓贴壁法体外分离、培养、纯化骨髓间充质干细胞的生物学特性、表型及多向分化潜能。方法:通过全骨髓贴壁法体外分离、培养、纯化大鼠骨髓间充质干细胞,进行形态学观察,流式细胞仪检测细胞标记物表达,分别进行成骨、成脂诱导分化。结果与结论:成功纯化、扩增了高细胞活性、高分化潜能的骨髓间充质干细胞。所得细胞呈成纤维细胞样;表达CD29、CD90,不表达CD45;成骨、成脂诱导分化后,茜素红染色、油红O染色阳性。证实全骨髓贴壁法操作简单、对细胞活性损伤小,可以得到高纯度、高活性、高分化潜能、生物学形态和特征稳定的骨髓间充质干细胞。 BACKGROUND:Bone marrow mesenchymal stem cells are rare in vivo. It is important to purify, proliferate and differentiate bone marrow mesenchymal stem cells in vitro for further research. OBJECTIVE:To evaluate the biological characteristics, phenotype and multiple differentiation potential cultivation of bone marrow mesenchymal stem cells that are isolated, cultured and purified using the whole bone marrow adherence method. METHODS:Bone marrow mesenchymal stem cells were isolated, purified and cultured by the whole bone marrow adherence method. Morphological observation and flow cytometry determination of cellsurface markers were performed. Osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells was induced. RESULTS AND CONCLUSION:We successful y purified and proliferated bone marrow mesenchymal stem cells with high cellviability and differentiation ability. Fibroblast-like cells were harvested, expressing CD29 and CD90, but not CD45. Fol owing osteogenic and adipogenic induction, cells were positive for oil red O staining and alizarin red staining. The whole bone marrow adherence method is easy to operate, has little impact on cellviability, and can be used to harvest high-purification bone marrow mesenchymal stem cells with high cellviability and differentiation ability.
出处 《中国组织工程研究》 CAS CSCD 2014年第10期1484-1489,共6页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金(81102160 81273038)~~
  • 相关文献

参考文献13

二级参考文献110

共引文献48

同被引文献71

  • 1王勇平,欧阳元明,蒋垚.成骨细胞分化及增殖调控的研究进展[J].上海交通大学学报(医学版),2011,31(10):1465-1469. 被引量:12
  • 2邓洪新,田聆,魏于全.基因治疗的发展现状、问题和展望[J].生命科学,2005,17(3):196-199. 被引量:36
  • 3Allen S J, Watson J J, Shoemark DK,et al.GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 2013; 138(2):155-175.
  • 4Colafrancesco V, Villoslada P.Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases.Arch Ital Biol. 2011;149(2): 183-192.
  • 5Saragovi HU, Gehring K.Development of pharmacological agents for targeting neurotrophins and their receptors.Trends Pharmacol Sci. 2000;21(3):93-98.
  • 6Kumar S, Chanda D, Ponnazhagan S.Therapeutic potential of genetically modified mesenchymal stem cells.Gene Ther. 2008; 15(10):711-715.
  • 7Gafni Y, Turgeman G, Liebergal M, et al.Stem cells as vehicles for orthopedic gene therapy.Gene Ther. 2004; 11(4): 417-426.
  • 8Fan BS, Lou JY.Recombinant expression of human nerve growth factor beta in rabbit bone marrow mesenchymal stem cells.Mol Biol Rep. 2010;37(8):4083-4090.
  • 9Rooney GE, Moran C, McMahon SS,et al.Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate.Tissue Eng Part A. 2008; 14(5):681-690.
  • 10Goins WF, Lee KA, Cavalcoli JD,et al.Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.J Virol. 1999;73(1):519-532.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部